InvaGen Pharmaceuticals Inc., affiliated to Cipla Ltd., is recalling one lot of Vigabatrin for Oral Solution, USP, citing leakage issues, according to the U.S Food and Drug Administration or FDA.
Cipla, in a regulatory filing, said InvaGen Pharmaceuticals is voluntarily recalling one lot of Vigabatrin for Oral Solution, USP (500 mg), at the consumer level due to seal integrity issues, allowing for powder leakage from the pouch